北京云菱生物技术有限公司

5

手机商铺

qrcode
商家活跃:
产品热度:
  • NaN
  • 0.20000000000000018
  • 0.20000000000000018
  • 1.2000000000000002
  • 0.20000000000000018

北京云菱生物技术有限公司

入驻年限:5

  • 联系人:

    崔圆圆

  • 所在地区:

    北京 大兴区

  • 业务范围:

    抗体、试剂、细胞库 / 细胞培养、ELISA 试剂盒、体外诊断

  • 经营模式:

    生产厂商

在线沟通
推荐产品

HPV假病毒

品牌:佑鑫

询价

询价

新冠病毒假病毒

品牌:佑鑫

询价

询价

抗体检测

品牌:佑鑫

询价

询价

HPV中和抗体质控品

品牌:佑鑫

询价

询价
查看全部产品

技术资料/正文

B.1.1.529 escapes the majority of SARS-CoV-2 neutralizing antibodies of 2 diverse epitopes

133 人阅读发布时间:2021-12-12 19:43

  1. Yunlong Cao1,2,#,*, Jing Wang1,3,#, Fanchong Jian1,4,#, Tianhe Xiao1,5,#, Weiliang

  2. 5  Song1,3,#, Ayijiang Yisimayi1,3,#, Weijin Huang6,#, Qianqian Li6, Peng Wang1,

  3. 6  Ran An1, Jing Wang1, Yao Wang1, Xiao Niu1,4, Sijie Yang1,7, Hui Liang1, Haiyan

  4. 7  Sun1, Tao Li6, Yuanling Yu6, Qianqian Cui6, Shuo Liu6, Xiaodong Yang8, Shuo

  5. 8  Du3, Zhiying Zhang3, Xiaohua Hao9, Fei Shao1, Ronghua Jin9, Xiangxi Wang10,*,

  6. 9  Junyu Xiao2,3,*, Youchun Wang6,*, Xiaoliang Sunney Xie1,2,*

10

  1. 11  1Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing,

  2. 12  P.R. China.

  3. 13  2Beijing Advanced Innovation Center for Genomics (ICG), Peking University,

  4. 14  Beijing, P.R. China.

  5. 15  3School of Life Sciences, Peking University, Beijing, P.R. China.

  6. 16  4College of Chemistry and Molecular Engineering, Peking University, Beijing,

  7. 17  P.R. China.

  8. 18  5Joint Graduate Program of Peking-Tsinghua-NIBS, Academy for Advanced

  9. 19  Interdisciplinary Studies, Peking University, Beijing, China.

  10. 20  6Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Institute for

  11. 21  Biological Product Control, National Institutes for Food and Drug Control

  12. 22  (NIFDC), and WHO Collaborating Center for Standardization and Evaluation of

  13. 23  Biologicals, Beijing, P.R. China.

  14. 24  7Tsinghua-Peking Center for Life Sciences, Beijing, P.R. China.

  15. 25  8Beijing YouAn Hospital, Capital Medical University, Beijing, P.R. China.

  16. 26  9Beijing Ditan Hospital, Capital Medical University, Beijing, P.R. China.

  17. 27  10CAS Key Laboratory of Infection and Immunity, National Laboratory of

  18. 28  Macromolecules, Institute of Biophysics, Chinese Academy of Sciences,

  19. 29  Beijing, P.R. China.

  20. 30  *Correspondence: Yunlong Cao (yunlongcao@pku.edu.cn); Junyu Xiao

  21. 31  (junyuxiao@pku.edu.cn); Xiangxi Wang (xiangxi@ibp.ac.cn); Youchun Wang

  22. 32  (wangyc@nifdc.org.cn); Xiaoliang Sunney Xie (sunneyxie@biopic.pku.edu.cn)

  23. 33  #These authors contributed equally.

资料格式:

2021.12.07.470392v1.full.pdf

查看详细文档

上一篇

The significant immune escape of pseudotyped SARS-CoV-2 Variant Omicron

下一篇

新型冠状病毒假病毒

我的询价